LITHIUM Safety Questions, LITHIUM Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LITHIUM. Our extensive database of LITHIUM adverse events and LITHIUM warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LITHIUM

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




LITHIUM Safety Reports

Total LITHIUM reports: 320.
LITHIUM FDA safety alerts: 2001 2004 .
Reported deaths: 34    Reported hospitalizations: 204.
Take LITHIUM Side Effects Survey or Share Your LITHIUM Story. LITHIUM Usage.

Showing 1-75 of 320 Next >

Consumer or non-health professional from reported LITHIUM problem on Mar 13, 2007. Female patient, 60 years of age, was diagnosed with bipolar disorder, nephrogenic diabetes insipidus and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus non-insulin-dependent, hypercalcaemia, hyperparathyroidism, hyperplasia, nephrogenic diabetes insipidus, polydipsia, polyuria. LITHIUM dosage: unknown. During the same period patient was treated with CHLORTHALIDONE. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Mar 12, 2007. Male patient, 63 years of age, weighting 260.1 lb, was diagnosed with bipolar disorder, asthma and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypercalcaemia, hyperparathyroidism, renal failure chronic. LITHIUM dosage: 450 MG DAILY. During the same period patient was treated with VALSARTAN, BUPROPION, IMIPRAMINE, ALBUTEROL. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on Mar 21, 2007. Male patient, 70 years of age, weighting 167.0 lb, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: chest pain, headache, paraesthesia. LITHIUM dosage: PO 2-300MG CAPS ONCE EVERY EVENING; ON 600 MG EVERY EVENING FOR 4-5 YEARS. During the same period patient was treated with SIMVASTATIN, CENTRUM SILVER, ASPIRIN. Patient recovered.

LITHIUM problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Female patient, 67 years of age, weighting 542.3 lb, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: confusional state, mental status changes, tremor. LITHIUM dosage: 300MG DAILY ORALLY. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Nov 23, 2004. Male patient, 51 years of age, weighting 180.0 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: tardive dyskinesia. LITHIUM dosage: unknown. During the same period patient was treated with ZOLOFT, KLINOPIN, LAMICTAL, RESTORIL, ZYPREXA, RISPERDAL, SEROQUEL. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from INDIA on Mar 13, 2007. Male patient, 28 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: neurological symptom, neurotoxicity. LITHIUM dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on Mar 29, 2007. Female patient, 57 years of age, weighting 195.0 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: aphasia, confusional state, coordination abnormal, hallucination, visual, therapeutic agent toxicity, urinary incontinence. LITHIUM dosage: 300 MG TID PO. During the same period patient was treated with TRAMADOL, PAROXETINE, NAPROXEN. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Physician from SPAIN on Mar 14, 2007. Male patient, weighting 14.99 lb, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: abnormal labour, amniocentesis abnormal, caesarean section, ebstein's anomaly, neonatal disorder. LITHIUM dosage: unknown. During the same period patient was treated with CLONAZEPAM. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LITHIUM problem on Apr 05, 2007. Female patient, 32 years of age, weighting 135.4 lb, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, polyuria, tremor, urine electrolytes decreased, vomiting, weight increased. LITHIUM dosage: 300MG Q12H - 900 MG TID (PO). Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 03, 2007. Female patient, 24 years of age, was diagnosed with bipolar disorder, contraception and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: alopecia, hepatic function abnormal, hypomania, menometrorrhagia. LITHIUM dosage: unknown. During the same period patient was treated with VENLAFAXINE, CARBAMAZEPINE, DIVALPROEX, LAMOTRIGINE, ORAL CONTRACEPTIVES. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported LITHIUM problem on Apr 09, 2007. Female patient, 18 years of age, weighting 114.6 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hepatic failure, thyroid disorder. LITHIUM dosage: 1,800 MG/DAY 3 TIMES A DAY. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Female patient, 50 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: mania. LITHIUM dosage: 300MG THREE TIMES PER DAY. During the same period patient was treated with PLAVIX, ASPIRIN, LEVOTHROID, XANAX, EXELON, MEVACOR, TOPAMAX, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE. Patient recovered.

Consumer or non-health professional from FRANCE reported LITHIUM problem on Apr 05, 2007. Female patient, 24 years of age, was diagnosed with depression, oral contraception and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypomania, menometrorrhagia. LITHIUM dosage: unknown. During the same period patient was treated with ETHINYL ESTRADIOL, GESTODENE, VENLAFAXINE. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 10, 2007. Female patient, 48 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hyperthyroidism, thyroiditis. LITHIUM dosage: unknown. Patient recovered.

Consumer or non-health professional from JAPAN reported LITHIUM problem on Mar 27, 2007. Male patient, 55 years of age, was diagnosed with schizophrenia and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: optic nerve disorder, papilloedema, visual acuity reduced. LITHIUM dosage: 600 MG, PER DAY; UNK. During the same period patient was treated with VALPROIC ACID, NITRAZEPAM, HALOPERIDOL, METHOTRIMEPRAZINE. Patient recovered.

LITHIUM problem was reported by a Physician from UNITED STATES on Mar 29, 2007. Male patient, 19 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. LITHIUM dosage: 600 MG; BID; PO. During the same period patient was treated with ARIPIPRAZOLE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Mar 15, 2006. Female patient, 21 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: nausea, nightmare, tremor. LITHIUM dosage: unknown. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2006. Female patient, 77 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: confusional state. LITHIUM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Apr 06, 2006. Female patient, 62 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. LITHIUM dosage: unknown. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2006. Female patient was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: adverse event. LITHIUM dosage: 300MG THREE TIMES PER DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on June 13, 2006. Male patient, 42 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: eating disorder, insomnia, sleep walking. LITHIUM dosage: unknown. During the same period patient was treated with NEURONTIN, LUVOX, KLONOPIN, ZOLOFT. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Female patient, 44 years of age, was diagnosed with bipolar disorder, hypertension and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: mania, renal failure chronic. LITHIUM dosage: unknown. During the same period patient was treated with LAMICTAL, SEROQUEL, KLONOPIN, LOTREL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Mar 13, 2006. Male patient, 51 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: dissociation, dizziness, feeling abnormal, stomach discomfort. LITHIUM dosage: 450MG TWICE PER DAY. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Female patient, 61 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: asthenia, bladder disorder, pain, pollakiuria, renal disorder. LITHIUM dosage: unknown. During the same period patient was treated with ESKALITH CR, SYNTHROID, PREMARIN, XANAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Apr 17, 2006. Female patient, 65 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: tremor. LITHIUM dosage: 900MG PER DAY. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 12, 2007. Female patient, 60 years of age, was diagnosed with mania, hypertension and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, dyskinesia, fall, gait disturbance, muscle rigidity, renal impairment, therapeutic agent toxicity. LITHIUM dosage: 900 - 1200 MG/DAY. During the same period patient was treated with LITHIUM CARBONATE, LITHIUM CARBONATE, VALSARTAN, VALPROATE, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LITHIUM problem on Apr 12, 2007. Male patient, 50 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: folliculitis, hypertrichosis, rash papular, rash pruritic, renal failure, sebaceous hyperplasia, squamous cell carcinoma. LITHIUM dosage: unknown. During the same period patient was treated with AZATHIOPRINE, CARBAMAZEPINE, CYCLOSPORINE. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Apr 11, 2007. Female patient, 60 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: mania, therapeutic agent toxicity. LITHIUM dosage: DAILY DOSE:600MG. During the same period patient was treated with VALSARTAN, VALPROATE, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LITHIUM problem on Apr 05, 2007. Female patient, 61 years of age, weighting 82.00 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: tremor. LITHIUM dosage: 2.5, 3.5 AND 3.6ML/DAY. During the same period patient was treated with CLONIDINE, PREDNISONE, PROGRAF, RAPAMUNE. Patient recovered.

LITHIUM problem was reported by a Physician from UNITED STATES on Apr 05, 2007. Female patient, 61 years of age, weighting 82.00 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: tremor. LITHIUM dosage: 2.5, 3.5 AND 3.6 ML/DAY; ORALLY. During the same period patient was treated with CLONIDINE, PREDNISONE, PROGRAF, RAPAMUNE. Patient recovered.

Health Professional from UNITED STATES reported LITHIUM problem on Apr 25, 2007. Female patient was diagnosed with bipolar disorder, schizoaffective disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: condition aggravated, psychiatric symptom. LITHIUM dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on Apr 26, 2007. Female patient, weighting 198.4 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: haemodialysis, renal failure chronic, renal transplant, therapeutic agent toxicity. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Apr 27, 2007. Female patient, 68 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypertension, palpitations, thrombosis. LITHIUM dosage: 450MG TWICE PER DAY. During the same period patient was treated with ASPIRIN. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 25, 2007. Female patient, 52 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, renal failure acute, therapeutic agent toxicity. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LITHIUM problem on Apr 25, 2007. Female patient, 44 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, erythema multiforme, renal failure acute, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, PERPHENAZINE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on Apr 25, 2007. Male patient, 57 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, renal failure acute, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE, PAROXETINE, VALPROIC ACID, PROPRANOLOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LITHIUM problem on Apr 25, 2007. Male patient, 55 years of age, was diagnosed with mania and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: headache, optic atrophy, papillitis, papilloedema, pupillary reflex impaired, vision blurred, visual acuity reduced. LITHIUM dosage: unknown. During the same period patient was treated with VALPROIC ACID, NITRAZEPAM, HALOPERIDOL, LEVOPROMAZINE, PIPERIDINE. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from GERMANY on Apr 24, 2007. Female patient, 38 years of age, was diagnosed with prophylaxis and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased, hepatic steatosis, hyperlipidaemia, impaired fasting glucose, lipase increased. LITHIUM dosage: unknown. During the same period patient was treated with RISPERIDONE, LORAZEPAM, PIPAMPERONE, ZOPICLON. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on May 04, 2007. Female patient, 50 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: encephalopathy, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with REVLIMID, TYLENOL, ACYCLOVIR, CEFEPIME, FOLIC ACID, HALDOL, SYNTHROID, ATIVAN. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Male patient, 57 years of age, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar syndrome, overdose, therapeutic agent toxicity. LITHIUM dosage: DAILY DOSE:600MG. During the same period patient was treated with CANNABIS, ALCOHOL, QUETIAPINE FUMARATE, PAROXETINE, VALPROIC ACID, PROPRANOLOL. Patient recovered.

Consumer or non-health professional from reported LITHIUM problem on May 02, 2007. Female patient, 64 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, bundle branch block right, cerebral atrophy, cerebrovascular accident, electrocardiogram t wave inversion, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with SERTRALINE, HALOPERIDOL. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Female patient, 44 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar syndrome, erythema multiforme, therapeutic agent toxicity. LITHIUM dosage: DAILY DOSE:1500MG. During the same period patient was treated with CARBAMAZEPINE, PERPHENAZINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Apr 26, 2007. Female patient, 52 years of age, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cerebellar syndrome, therapeutic agent toxicity. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2007. Female patient, 39 years of age, weighting 195.0 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: cardiac flutter, confusional state, constipation, coordination abnormal, diarrhoea, dysarthria, dyskinesia, fall, fatigue. LITHIUM dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on May 07, 2007. Male patient, 51 years of age, weighting 271.4 lb, was diagnosed with affective disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, diarrhoea, hyponatraemia, nausea, oral intake reduced, vomiting. LITHIUM dosage: 600 MG PO BID WITH FOOD. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on May 09, 2007. Female patient, 32 years of age, was diagnosed with intentional overdose and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: intentional overdose, suicide attempt, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with CLORAZEPATE, CLOMIPRAMINE, LORAZEPAM, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LITHIUM problem on May 09, 2007. Male patient, 64 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: bradycardia, hypotension, presyncope, sinus arrest, sinus arrhythmia. LITHIUM dosage: 1200 MG QD. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on May 10, 2007. Male patient, 59 years of age, was diagnosed with schizophrenia and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dialysis, mental status changes, rebound effect, therapeutic agent toxicity. LITHIUM dosage: 150MG DAILY PO. During the same period patient was treated with COMBIVENT, XOPENEX, MOMETASONE FUROATE, ASPIRIN, KLONOPIN, METOPROLOL TARTRATE, TRAZODONE, RISPERDAL. Patient was hospitalized. Patient died on 01/02/2007.

Consumer or non-health professional from UNITED KINGDOM reported LITHIUM problem on May 14, 2007. Male patient, 63 years of age, was diagnosed with bipolar disorder, convulsion, left ventricular failure and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: nephrogenic diabetes insipidus, renal failure acute. LITHIUM dosage: unknown. During the same period patient was treated with ARIPIPRAZOLE, EPILIM, FRUSEMIDE, OMEPRAZOLE, POTASSIUM SULPHATE, RAMIPRIL. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on May 15, 2007. Male patient, child 11 years of age, was diagnosed with post-traumatic stress disorder, tremor and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: anticholinergic syndrome, cogwheel rigidity, confusional state, dry mouth, dry skin, fatigue, hypokinesia, malaise, oral candidiasis. LITHIUM dosage: unknown. During the same period patient was treated with CHLORPROMAZINE, BENZTROPINE, RISPERIDONE, VALPROIC ACID. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported LITHIUM problem on May 02, 2007. Female patient, 38 years of age, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: glucose tolerance impaired, hypercholesterolaemia, hypertriglyceridaemia, lipase increased. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Physician from TAIWAN, PROVINCE OF CHINA on May 02, 2007. Female patient, 60 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: azotaemia, coordination abnormal, fall, gait disturbance, hypokinesia, mania, muscle rigidity. LITHIUM dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, VALPROATE, CLONAZEPAM, VALSARTAN, RISPERIDONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CANADA reported LITHIUM problem on May 02, 2007. Male patient, 65 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: anion gap decreased, blood bicarbonate increased, blood calcium increased, depressed level of consciousness, dysarthria, haemodialysis, heart rate increased, osmolar gap abnormal, overdose. LITHIUM dosage: 300 MG. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Physician from UNITED STATES on May 03, 2007. Male patient, 17 years of age, was diagnosed with schizophrenia, catatonic type and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, coordination abnormal, delusion, disorientation, extrapyramidal disorder, inappropriate affect. LITHIUM dosage: 900 MG; QD; PO. During the same period patient was treated with ZIPRASIDONE. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LITHIUM problem on May 15, 2007. Female patient, 71 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: motor neurone disease. LITHIUM dosage: unknown. Patient died on 01/01/2007.

LITHIUM problem was reported by a Consumer or non-health professional from on May 22, 2007. Female patient, 43 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, bradycardia, hypochloraemia, hypokalaemia, hypotension, hypothermia, metabolic alkalosis, sinoatrial block, therapeutic agent toxicity. LITHIUM dosage: 600 MG BID. During the same period patient was treated with NAPROXEN, MIRTAZAPINE, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LITHIUM problem on May 11, 2007. Male patient, 19 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome, no therapeutic response. LITHIUM dosage: unknown. During the same period patient was treated with ARIPIPRAZOLE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on May 24, 2007. Male patient, 60 years of age, weighting 184.1 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypernatraemia, nephrogenic diabetes insipidus. LITHIUM dosage: 150 MG PO Q6 HRS (DURATION: } 1YEAR PTA). Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SPAIN reported LITHIUM problem on May 16, 2007. Female patient, 32 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: haemodialysis, intentional overdose, therapeutic agent toxicity. LITHIUM dosage: unknown. During the same period patient was treated with CLORAZEPATE MONOPOTASSIUM, CLOMIPRAMINE, LORAZEPAM, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on May 31, 2007. Male patient, 48 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, confusional state, convulsion, tremor. LITHIUM dosage: 450MG HS PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on May 29, 2007. Female patient, 27 years of age, was diagnosed with bipolar i disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, haemodialysis, nausea, therapeutic agent toxicity. LITHIUM dosage: unknown. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from on May 31, 2007. Male patient, 65 years of age, was diagnosed with bipolar disorder, hypertension and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: anion gap abnormal, depressed level of consciousness, osmolar gap abnormal, overdose. LITHIUM dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on May 29, 2007. Female patient, 43 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate increased, blood creatinine increased, bradycardia, electrocardiogram qrs complex shortened, electrocardiogram t wave amplitude decreased, haemodialysis, hypochloraemia, hypokalaemia. LITHIUM dosage: unknown. During the same period patient was treated with NAPROXEN, AMITRIPTYLINE, MIRTAZAPINE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from TURKEY on May 29, 2007. Female patient, 54 years of age, was diagnosed with mania and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, extrapyramidal disorder, hyperthyroidism, neuroleptic malignant syndrome, pneumonia, thalassaemia beta. LITHIUM dosage: DAILY DOSE:1200MG. During the same period patient was treated with RISPERIDONE, BIPERIDEN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on June 11, 2007. Female patient, 55 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: agitation, muscle twitching, neuromyopathy, therapeutic agent toxicity, tremor. LITHIUM dosage: 600MG DAILY PO. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on June 14, 2007. Male patient, weighting 180.0 lb, was diagnosed with irritability and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: balance disorder, communication disorder, hypotonia, ill-defined disorder, myoclonus, posture abnormal, spinal disorder, tremor. LITHIUM dosage: 300 MG BID TO TID TO BID PO. During the same period patient was treated with LITHIUM CARBONATE, FAZACLO ODT, INVEGA, LISINOPRIL, ATROPINE, RISPERDAL, DEPAKOTE ER. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on June 19, 2007. Male patient, weighting 168.0 lb, was diagnosed with bipolar disorder, schizophrenia and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine increased, hepatic steatosis, hypernatraemia, lethargy, mental status changes, nephrogenic diabetes insipidus. LITHIUM dosage: 300MG BID PO. During the same period patient was treated with LITHIUM CARBONATE. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Pharmacist from UNITED STATES on June 19, 2007. Male patient, 59 years of age, weighting 191.8 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: headache, nausea, tremor. LITHIUM dosage: 600MG/900MG QAM/QHS PO. Patient was hospitalized. Patient recovered.

Physician from POLAND reported LITHIUM problem on June 11, 2007. Female patient, 71 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: asthenia, bradycardia, hypotonia, mental disorder, therapeutic agent toxicity. LITHIUM dosage: 1000 MG,. During the same period patient was treated with DIGOXIN, CARBAMAZEPINE, FUROSEMIDE. Patient recovered.

LITHIUM problem was reported by a Physician from SPAIN on June 08, 2007. Male patient, 29 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, addison's disease, adrenocortical insufficiency acute, anorexia, asthenia, autoimmune disorder, condition aggravated, dehydration, dizziness. LITHIUM dosage: unknown. During the same period patient was treated with FLUDROCORTISONE ACETATE, PERICYAZINE, LORAZEPAM, HYDROCORTISONE, HALOPERIDOL, PREDNISONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on Aug 28, 2006. Female patient, 57 years of age, weighting 148.0 lb, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. LITHIUM dosage: 300 MG. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 19, 2007. Female patient, 31 years of age, was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, oligomenorrhoea, suicide attempt. LITHIUM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LITHIUM problem on June 21, 2007. Male patient, weighting 160.1 lb, was diagnosed with bipolar disorder and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: angioedema, urticaria. LITHIUM dosage: unknown. During the same period patient was treated with LAMICTAL, ABILIFY. Patient was hospitalized. Patient recovered.

LITHIUM problem was reported by a Consumer or non-health professional from GERMANY on June 13, 2007. Female patient, 33 years of age, weighting 185.2 lb, was diagnosed with depression and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: glucose tolerance impaired, hepatic steatosis, hypercholesterolaemia, hyperlipidaemia, hypertriglyceridaemia, impaired fasting glucose, lipase increased, mixed hyperlipidaemia. LITHIUM dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LITHIUM problem on July 11, 2006. Male patient, weighting 255.7 lb, was diagnosed with bipolar disorder, incontinence and was treated with LITHIUM. After drug was administered, patient experienced the following problems/side effects: diabetes insipidus, incontinence, micturition urgency, nocturia. LITHIUM dosage: 300MG/600MG DAILY PO. During the same period patient was treated with BETHANECHOL, TRAZODONE, PROZAC, BUPROPION, NEURONTIN, VALPROIC ACID, TEMAZEPAM, CLONAZEPAM. Patient recovered.

Showing 1-75 of 320 Next >

Ask Our Patient Community about LITHIUM

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)